Kimelman & Baird LLC Takes Position in Sensient Technologies Corporation $SXT

Kimelman & Baird LLC bought a new position in shares of Sensient Technologies Corporation (NYSE:SXT) in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 16,650 shares of the specialty chemicals company’s stock, valued at approximately $2,053,000.

Several other hedge funds also recently made changes to their positions in SXT. MML Investors Services LLC raised its position in Sensient Technologies by 3.9% during the fourth quarter. MML Investors Services LLC now owns 3,146 shares of the specialty chemicals company’s stock worth $296,000 after acquiring an additional 119 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its stake in shares of Sensient Technologies by 1.4% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 9,675 shares of the specialty chemicals company’s stock valued at $909,000 after purchasing an additional 130 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in Sensient Technologies by 53.1% in the 4th quarter. Advisors Asset Management Inc. now owns 401 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 139 shares in the last quarter. Covestor Ltd grew its stake in shares of Sensient Technologies by 31.7% in the fourth quarter. Covestor Ltd now owns 594 shares of the specialty chemicals company’s stock worth $56,000 after purchasing an additional 143 shares during the last quarter. Finally, Evergreen Capital Management LLC raised its holdings in Sensient Technologies by 3.4% during the 2nd quarter. Evergreen Capital Management LLC now owns 4,500 shares of the specialty chemicals company’s stock worth $443,000 after purchasing an additional 146 shares during the last quarter. 90.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently commented on SXT. Zacks Research upgraded Sensient Technologies from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 27th. Rothschild & Co Redburn assumed coverage on shares of Sensient Technologies in a research report on Wednesday, July 8th. They issued a “neutral” rating and a $125.00 price target on the stock. Robert W. Baird lifted their price objective on shares of Sensient Technologies from $125.00 to $140.00 and gave the stock an “outperform” rating in a report on Monday, July 27th. Weiss Ratings lowered Sensient Technologies from a “buy (b)” rating to a “buy (b-)” rating in a report on Wednesday. Finally, UBS Group lifted their price objective on shares of Sensient Technologies from $143.00 to $155.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $140.00.

Insider Buying and Selling at Sensient Technologies

In other news, Director Mario Ferruzzi sold 1,200 shares of the company’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $129.48, for a total value of $155,376.00. Following the transaction, the director owned 7,352 shares in the company, valued at approximately $951,936.96. This represents a 14.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 1.30% of the stock is owned by insiders.

Sensient Technologies Trading Up 0.9%

Shares of SXT opened at $134.87 on Friday. The firm has a 50 day moving average price of $124.29 and a 200-day moving average price of $110.28. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.72 and a current ratio of 4.39. Sensient Technologies Corporation has a fifty-two week low of $82.60 and a fifty-two week high of $138.82. The firm has a market cap of $5.74 billion, a price-to-earnings ratio of 36.35 and a beta of 0.78.

Sensient Technologies (NYSE:SXT) last released its quarterly earnings data on Friday, July 24th. The specialty chemicals company reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.17. Sensient Technologies had a return on equity of 13.77% and a net margin of 9.27%.The firm had revenue of $462.08 million during the quarter, compared to analyst estimates of $448.84 million. During the same quarter in the prior year, the firm posted $0.88 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. Sensient Technologies has set its FY 2026 guidance at 4.100-4.200 EPS. As a group, equities research analysts forecast that Sensient Technologies Corporation will post 4.2 earnings per share for the current year.

Sensient Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Investors of record on Monday, August 3rd will be given a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Monday, August 3rd. Sensient Technologies’s dividend payout ratio (DPR) is 44.20%.

Sensient Technologies Profile

Sensient Technologies Corporation is a global leader in the manufacture and supply of colors, flavors and fragrances for a broad range of end-markets. The company develops and produces ingredients that enhance the appearance, taste and scent of products in the food, beverage, nutraceutical, pharmaceutical, personal care and household sectors. Its portfolio includes natural and synthetic colorants, botanical and artificial flavor systems, fragrance compounds and specialty chemical offerings tailored to customer specifications.

Within its flavor and fragrance division, Sensient provides custom formulations for sweet, savory and umami taste profiles along with fragrance blends for personal care and cosmetic applications.